Venetoclax Plus Decitabine for Young Adults with Newly Diagnosed ELN Adverse-Risk Acute Myeloid Leukemia: Updated Results of a Phase 2 Trial

Venetoclax Plus Decitabine for Young Adults with Newly Diagnosed ELN Adverse-Risk Acute Myeloid Leukemia: Updated Results of a Phase 2 Trial

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2022-11, Vol.140 (Supplement 1), p.1439-1440
Hauptverfasser: Xie, Jundan, Yang, Xiaofei, Bao, Xiebing, Shen, Hongjie, Cen, Jiannong, Yao, Li, Hu, Xiaohui, Wu, Qian, Zhang, Jingren, He, Xuefeng, Tang, Xiaowen, Sun, AiNing, Qiu, Hongchun, Xue, Shengli, Wang, Ying, Fu, Jianhong, Qiu, Huiying, Wu, Depei, Chen, Suning
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1440
container_issue Supplement 1
container_start_page 1439
container_title Blood
container_volume 140
creator Xie, Jundan
Yang, Xiaofei
Bao, Xiebing
Shen, Hongjie
Cen, Jiannong
Yao, Li
Hu, Xiaohui
Wu, Qian
Zhang, Jingren
He, Xuefeng
Tang, Xiaowen
Sun, AiNing
Qiu, Hongchun
Xue, Shengli
Wang, Ying
Fu, Jianhong
Qiu, Huiying
Wu, Depei
Chen, Suning
description
doi_str_mv 10.1182/blood-2022-166384
format Article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2022_166384</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497122021462</els_id><sourcerecordid>S0006497122021462</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1374-aa902b3472c2f2f61e53b7a6861451858eadb269ccc39cfed9aee882d39c88733</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EEqXwAezmBwK283JgVZXykEqpqhaJVeTYk2JIY2QnLf0HPpq0Zc1qdDU6V1eHkEtGrxgT_LqorNUBp5wHLElCER2RHou5CCjl9Jj0KKVJEGUpOyVn3n9QyqKQxz3y84o1NlZV8humVevhDpVpZGFqhNI6eLNtvYSBbqvGw8Y07zDBTbWFOyOXtfWoYTSedP81Oo_BzPhPGKi2QXjeYmWNhjG2n7gy8gYWX1o2HTBDv2-zJUiYvkuPwGHujKzOyUkpK48Xf7dPFvej-fAxGL88PA0H40CxMI0CKTPKizBKueIlLxOGcVikMhEJi2ImYoFSFzzJlFJhpkrUmUQUgusuCZGGYZ-wQ69y1nuHZf7lzEq6bc5ovtOZ73XmO535QWfH3B4Y7IatDbrcK4O1Qm0cqibX1vxD_wJpmX5p</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Venetoclax Plus Decitabine for Young Adults with Newly Diagnosed ELN Adverse-Risk Acute Myeloid Leukemia: Updated Results of a Phase 2 Trial</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Xie, Jundan ; Yang, Xiaofei ; Bao, Xiebing ; Shen, Hongjie ; Cen, Jiannong ; Yao, Li ; Hu, Xiaohui ; Wu, Qian ; Zhang, Jingren ; He, Xuefeng ; Tang, Xiaowen ; Sun, AiNing ; Qiu, Hongchun ; Xue, Shengli ; Wang, Ying ; Fu, Jianhong ; Qiu, Huiying ; Wu, Depei ; Chen, Suning</creator><creatorcontrib>Xie, Jundan ; Yang, Xiaofei ; Bao, Xiebing ; Shen, Hongjie ; Cen, Jiannong ; Yao, Li ; Hu, Xiaohui ; Wu, Qian ; Zhang, Jingren ; He, Xuefeng ; Tang, Xiaowen ; Sun, AiNing ; Qiu, Hongchun ; Xue, Shengli ; Wang, Ying ; Fu, Jianhong ; Qiu, Huiying ; Wu, Depei ; Chen, Suning</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2022-166384</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Blood, 2022-11, Vol.140 (Supplement 1), p.1439-1440</ispartof><rights>2022 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids></links><search><creatorcontrib>Xie, Jundan</creatorcontrib><creatorcontrib>Yang, Xiaofei</creatorcontrib><creatorcontrib>Bao, Xiebing</creatorcontrib><creatorcontrib>Shen, Hongjie</creatorcontrib><creatorcontrib>Cen, Jiannong</creatorcontrib><creatorcontrib>Yao, Li</creatorcontrib><creatorcontrib>Hu, Xiaohui</creatorcontrib><creatorcontrib>Wu, Qian</creatorcontrib><creatorcontrib>Zhang, Jingren</creatorcontrib><creatorcontrib>He, Xuefeng</creatorcontrib><creatorcontrib>Tang, Xiaowen</creatorcontrib><creatorcontrib>Sun, AiNing</creatorcontrib><creatorcontrib>Qiu, Hongchun</creatorcontrib><creatorcontrib>Xue, Shengli</creatorcontrib><creatorcontrib>Wang, Ying</creatorcontrib><creatorcontrib>Fu, Jianhong</creatorcontrib><creatorcontrib>Qiu, Huiying</creatorcontrib><creatorcontrib>Wu, Depei</creatorcontrib><creatorcontrib>Chen, Suning</creatorcontrib><title>Venetoclax Plus Decitabine for Young Adults with Newly Diagnosed ELN Adverse-Risk Acute Myeloid Leukemia: Updated Results of a Phase 2 Trial</title><title>Blood</title><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kMtOwzAQRS0EEqXwAezmBwK283JgVZXykEqpqhaJVeTYk2JIY2QnLf0HPpq0Zc1qdDU6V1eHkEtGrxgT_LqorNUBp5wHLElCER2RHou5CCjl9Jj0KKVJEGUpOyVn3n9QyqKQxz3y84o1NlZV8humVevhDpVpZGFqhNI6eLNtvYSBbqvGw8Y07zDBTbWFOyOXtfWoYTSedP81Oo_BzPhPGKi2QXjeYmWNhjG2n7gy8gYWX1o2HTBDv2-zJUiYvkuPwGHujKzOyUkpK48Xf7dPFvej-fAxGL88PA0H40CxMI0CKTPKizBKueIlLxOGcVikMhEJi2ImYoFSFzzJlFJhpkrUmUQUgusuCZGGYZ-wQ69y1nuHZf7lzEq6bc5ovtOZ73XmO535QWfH3B4Y7IatDbrcK4O1Qm0cqibX1vxD_wJpmX5p</recordid><startdate>20221115</startdate><enddate>20221115</enddate><creator>Xie, Jundan</creator><creator>Yang, Xiaofei</creator><creator>Bao, Xiebing</creator><creator>Shen, Hongjie</creator><creator>Cen, Jiannong</creator><creator>Yao, Li</creator><creator>Hu, Xiaohui</creator><creator>Wu, Qian</creator><creator>Zhang, Jingren</creator><creator>He, Xuefeng</creator><creator>Tang, Xiaowen</creator><creator>Sun, AiNing</creator><creator>Qiu, Hongchun</creator><creator>Xue, Shengli</creator><creator>Wang, Ying</creator><creator>Fu, Jianhong</creator><creator>Qiu, Huiying</creator><creator>Wu, Depei</creator><creator>Chen, Suning</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221115</creationdate><title>Venetoclax Plus Decitabine for Young Adults with Newly Diagnosed ELN Adverse-Risk Acute Myeloid Leukemia: Updated Results of a Phase 2 Trial</title><author>Xie, Jundan ; Yang, Xiaofei ; Bao, Xiebing ; Shen, Hongjie ; Cen, Jiannong ; Yao, Li ; Hu, Xiaohui ; Wu, Qian ; Zhang, Jingren ; He, Xuefeng ; Tang, Xiaowen ; Sun, AiNing ; Qiu, Hongchun ; Xue, Shengli ; Wang, Ying ; Fu, Jianhong ; Qiu, Huiying ; Wu, Depei ; Chen, Suning</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1374-aa902b3472c2f2f61e53b7a6861451858eadb269ccc39cfed9aee882d39c88733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xie, Jundan</creatorcontrib><creatorcontrib>Yang, Xiaofei</creatorcontrib><creatorcontrib>Bao, Xiebing</creatorcontrib><creatorcontrib>Shen, Hongjie</creatorcontrib><creatorcontrib>Cen, Jiannong</creatorcontrib><creatorcontrib>Yao, Li</creatorcontrib><creatorcontrib>Hu, Xiaohui</creatorcontrib><creatorcontrib>Wu, Qian</creatorcontrib><creatorcontrib>Zhang, Jingren</creatorcontrib><creatorcontrib>He, Xuefeng</creatorcontrib><creatorcontrib>Tang, Xiaowen</creatorcontrib><creatorcontrib>Sun, AiNing</creatorcontrib><creatorcontrib>Qiu, Hongchun</creatorcontrib><creatorcontrib>Xue, Shengli</creatorcontrib><creatorcontrib>Wang, Ying</creatorcontrib><creatorcontrib>Fu, Jianhong</creatorcontrib><creatorcontrib>Qiu, Huiying</creatorcontrib><creatorcontrib>Wu, Depei</creatorcontrib><creatorcontrib>Chen, Suning</creatorcontrib><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xie, Jundan</au><au>Yang, Xiaofei</au><au>Bao, Xiebing</au><au>Shen, Hongjie</au><au>Cen, Jiannong</au><au>Yao, Li</au><au>Hu, Xiaohui</au><au>Wu, Qian</au><au>Zhang, Jingren</au><au>He, Xuefeng</au><au>Tang, Xiaowen</au><au>Sun, AiNing</au><au>Qiu, Hongchun</au><au>Xue, Shengli</au><au>Wang, Ying</au><au>Fu, Jianhong</au><au>Qiu, Huiying</au><au>Wu, Depei</au><au>Chen, Suning</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Venetoclax Plus Decitabine for Young Adults with Newly Diagnosed ELN Adverse-Risk Acute Myeloid Leukemia: Updated Results of a Phase 2 Trial</atitle><jtitle>Blood</jtitle><date>2022-11-15</date><risdate>2022</risdate><volume>140</volume><issue>Supplement 1</issue><spage>1439</spage><epage>1440</epage><pages>1439-1440</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><pub>Elsevier Inc</pub><doi>10.1182/blood-2022-166384</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2022-11, Vol.140 (Supplement 1), p.1439-1440
issn 0006-4971
1528-0020
language eng
recordid cdi_crossref_primary_10_1182_blood_2022_166384
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
title Venetoclax Plus Decitabine for Young Adults with Newly Diagnosed ELN Adverse-Risk Acute Myeloid Leukemia: Updated Results of a Phase 2 Trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T09%3A10%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Venetoclax%20Plus%20Decitabine%20for%20Young%20Adults%20with%20Newly%20Diagnosed%20ELN%20Adverse-Risk%20Acute%20Myeloid%20Leukemia:%20Updated%20Results%20of%20a%20Phase%202%20Trial&rft.jtitle=Blood&rft.au=Xie,%20Jundan&rft.date=2022-11-15&rft.volume=140&rft.issue=Supplement%201&rft.spage=1439&rft.epage=1440&rft.pages=1439-1440&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2022-166384&rft_dat=%3Celsevier_cross%3ES0006497122021462%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0006497122021462&rfr_iscdi=true